1. Home
  2. GLU vs IXHL Comparison

GLU vs IXHL Comparison

Compare GLU & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$21.28

Market Cap

119.8M

Sector

Finance

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.81

Market Cap

97.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
IXHL
Founded
2004
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.8M
97.6M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
GLU
IXHL
Price
$21.28
$3.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4K
5.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.07
$0.11
52 Week High
$21.69
$5.17

Technical Indicators

Market Signals
Indicator
GLU
IXHL
Relative Strength Index (RSI) 57.40 85.57
Support Level $17.78 $0.32
Resistance Level $21.69 N/A
Average True Range (ATR) 0.40 0.17
MACD -0.05 0.43
Stochastic Oscillator 39.03 72.68

Price Performance

Historical Comparison
GLU
IXHL

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: